{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:40:48Z","timestamp":1792636848752,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annalsofvascularsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.avsg.2018.05.051","type":"journal-article","created":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T12:30:38Z","timestamp":1533558638000},"page":"55-62.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Comparison of the Cost of Drug-Eluting Stents versus Bare Metal Stents in the Treatment of Critical Limb Ischemia in the United States"],"prefix":"10.1016","volume":"55","author":[{"given":"Satinderjit S.","family":"Locham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawar","family":"Paracha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanaa","family":"Dakour-Aridi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Besma","family":"Nejim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Rizwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud B.","family":"Malas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2018.05.051_bib1","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.avsg.2018.05.051_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/j.tvir.2016.04.001","article-title":"Epidemiology of peripheral arterial disease and critical limb ischemia","volume":"19","author":"Dua","year":"2016","journal-title":"Tech Vasc Interv Radiol"},{"key":"10.1016\/j.avsg.2018.05.051_bib3","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.avsg.2015.11.026","article-title":"Preventable complications driving rising costs in management of patients with critical limb ischemia","volume":"33","author":"Dua","year":"2016","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.avsg.2018.05.051_bib4","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.jvs.2009.02.014","article-title":"Predicting ambulation status one year after lower extremity bypass","volume":"49","author":"Goodney","year":"2009","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2018.05.051_bib5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jvs.2013.05.100","article-title":"Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease","volume":"59","author":"Malas","year":"2014","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2018.05.051_bib6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jvs.2009.01.035","article-title":"National trends in lower extremity bypass surgery, endovascular interventions, and major amputations","volume":"50","author":"Goodney","year":"2009","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2018.05.051_bib7","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/jamasurg.2014.369","article-title":"Design of the revascularization with open bypass vs angioplasty and stenting of the lower extremity trial (ROBUST): a randomized clinical trial","volume":"149","author":"Malas","year":"2014","journal-title":"JAMA Surg"},{"key":"10.1016\/j.avsg.2018.05.051_bib8","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.115.016900","article-title":"Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the zilver PTX randomized trial","volume":"133","author":"Dake","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2018.05.051_bib9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/03007995.2017.1372114","article-title":"Drug-delivering endovascular treatment versus angioplasty in artery occlusion diseases: a systematic review and meta-analysis","volume":"34","author":"Chen","year":"2018","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.avsg.2018.05.051_bib10","series-title":"Premier Research Services Creates Insights Through Data Web Site","year":"2017"},{"key":"10.1016\/j.avsg.2018.05.051_bib11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00019501-200205000-00008","article-title":"Twenty-eight-day efficacy and phamacokinetics of the sirolimus-eluting stent","volume":"13","author":"Klugherz","year":"2002","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.avsg.2018.05.051_bib12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0140-6736(03)12275-1","article-title":"Drug-eluting stents in vascular intervention","volume":"361","author":"Fattori","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.avsg.2018.05.051_bib13","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00270-012-0494-x","article-title":"A budget impact model for paclitaxel-eluting stent in femoropopliteal disease in France","volume":"36","author":"De Cock","year":"2013","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.avsg.2018.05.051_bib14","first-page":"546","article-title":"Economic analysis of endovascular interventions for femoropopliteal arterial disease: a systematic review and budget impact model for the United States and Germany","volume":"84","author":"Pietzsch","year":"2014","journal-title":"Catheterization Cardiovasc Interventions"},{"key":"10.1016\/j.avsg.2018.05.051_bib15","doi-asserted-by":"crossref","first-page":"e013460","DOI":"10.1136\/bmjopen-2016-013460","article-title":"Cost-effectiveness of superficial femoral artery endovascular interventions in the UK and Germany: a modelling study","volume":"7","author":"Kearns","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.avsg.2018.05.051_bib16","doi-asserted-by":"crossref","first-page":"e011245","DOI":"10.1136\/bmjopen-2016-011245","article-title":"Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK","volume":"6","author":"Katsanos","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.avsg.2018.05.051_bib17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/1358863X08089277","article-title":"National health care costs of peripheral arterial disease in the medicare population","volume":"13","author":"Hirsch","year":"2008","journal-title":"Vasc Med"},{"key":"10.1016\/j.avsg.2018.05.051_bib18","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jacc.2014.12.048","article-title":"Trends in settings for peripheral vascular intervention and the effect of changes in the outpatient prospective payment system","volume":"65","author":"Jones","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2018.05.051_bib19","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jvs.2009.09.056","article-title":"Future of vascular surgery is in the office","volume":"51","author":"Jain","year":"2010","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2018.05.051_bib20","first-page":"987.e25","article-title":"Disparities in the use of drug-eluting coronary stents by race, ethnicity, payer, and hospital","volume":"32","author":"Hannan","year":"2016","journal-title":"Can J Cardiol"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509618305521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509618305521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:52:39Z","timestamp":1760187159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890509618305521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":20,"alternative-id":["S0890509618305521"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2018.05.051","relation":{},"ISSN":["0890-5096"],"issn-type":[{"value":"0890-5096","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the Cost of Drug-Eluting Stents versus Bare Metal Stents in the Treatment of Critical Limb Ischemia in the United States","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2018.05.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}